Clinical trial · Observational
Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging
NCT06260358CI-TRIAL-00087128STRECCrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to validate a structured report for cervical cancer anchored to the FIGO staging system. A structured report is hypothesized to aid in uniformly applying FIGO staging, reducing staging discrepancies and improving patient care and outcomes. Furthermore, we believe that the participation of the clinicians will improve the quality of the report to minimize the need for multidisciplinary team discussion
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Efficacy of a contextual structured report
- timeFrame
- 1 year
- description
- Primary endpoint of the study is to assess referring physicians' (gynecologists and radiation oncologists) overall satisfaction rate with structured reports for staging MRI of patients with cervical cancer, in terms of overall response rate ≥4 at the first 5 items (i.e., an overall score ≥20)
Secondary outcomes (3)
- measure
- Satisfaction rate with narrative and structured report
- timeFrame
- 1 year
- description
- To investigate the satisfaction rate of physicians between narrative and structured report
- measure
- Comparison Single items response rate, on both narrative and structured reports
- timeFrame
- 1 year
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥18 years old; * Overt biopsy-proven diagnosis of cervical cancer, at any stage; * Signed written informed consent to personal data treatment for research purposes Exclusion Criteria: * Age \<18 years old; * Uncertain diagnosis of cervical cancer; * MRI scan not according the standard acquisition protocol (ESUR guidelines); * Patients candidate to non-standard treatments; * Refusal to sign the written informed consent to personal data treatment for research purposes
References
Publications (0)
Data not yet available
No reference posted for this study.